Cargando…
Waning and boosting of antibody Fc-effector functions upon SARS-CoV-2 vaccination
Since the emergence of SARS-CoV-2, vaccines targeting COVID-19 have been developed with unprecedented speed and efficiency. CoronaVac, utilising an inactivated form of the COVID-19 virus and the mRNA26 based Pfizer/BNT162b2 vaccines are widely distributed. Beyond the ability of vaccines to induce pr...
Autores principales: | Tong, X., McNamara, R. P., Avendaño, M. J., Serrano, E. F., García-Salum, T., Pardo-Roa, C., Bertera, H. L., Chicz, T. M., Levican, J., Poblete, E., Salinas, E., Muñoz, A., Riquelme, A., Alter, G., Medina, R. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345146/ https://www.ncbi.nlm.nih.gov/pubmed/37443074 http://dx.doi.org/10.1038/s41467-023-39189-8 |
Ejemplares similares
-
Waning and boosting of functional humoral immunity to SARS-CoV-2
por: Tong, X., et al.
Publicado: (2022) -
Preserved Omicron Spike specific antibody binding and Fc-recognition across COVID-19 vaccine platforms
por: Bartsch, Yannic, et al.
Publicado: (2021) -
Fcγ receptor-dependent antibody effector functions are required for vaccine protection against infection by antigenic variants of SARS-CoV-2
por: Mackin, Samantha R., et al.
Publicado: (2022) -
Waning and boosting: on the dynamics of immune status
por: Diekmann, O., et al.
Publicado: (2018) -
Long-lasting neutralizing antibody responses in SARS-CoV-2 seropositive individuals are robustly boosted by immunization with the CoronaVac and BNT162b2 vaccines
por: Muena, Nicolás A., et al.
Publicado: (2021)